Valion Bio, Inc. (VBIO) stock
VBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/30
$0.54+0.01 (+2.72%)
Close on Nov 17, 2026Market cap $2.26MP/E –Yield –
Valion Bio total assets
Total assets on the balance sheet at the end of each period.
Valion Bio's total assets was $32.47M at Jun 30, 2026. For fiscal 2025 it was $31.61M, up 1026.0% from the year before. The highest annual figure on record is $31.61M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.61M | +1026.0% |
| FY2024 | Dec 31, 2024 | $2.81M | -45.6% |
| FY2023 | Dec 31, 2023 | $5.16M | -12.2% |
| FY2022 | Dec 31, 2022 | $5.88M | -60.9% |
| FY2021 | Dec 31, 2021 | $15.04M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $32.47M | +620.3% |
| Q1 FY2026 | Mar 31, 2026 | $38.22M | +911.8% |
| Q4 FY2025 | Dec 31, 2025 | $31.61M | +1026.0% |
| Q3 FY2025 | Sep 30, 2025 | $6.23M | +83.5% |
| Q2 FY2025 | Jun 30, 2025 | $4.51M | -5.7% |
| Q1 FY2025 | Mar 31, 2025 | $3.78M | +14.9% |
| Q4 FY2024 | Dec 31, 2024 | $2.81M | -45.6% |
| Q3 FY2024 | Sep 30, 2024 | $3.39M | -51.6% |
| Q2 FY2024 | Jun 30, 2024 | $4.78M | +4.1% |
| Q1 FY2024 | Mar 31, 2024 | $3.29M | -53.7% |
| Q4 FY2023 | Dec 31, 2023 | $5.16M | -12.2% |
| Q3 FY2023 | Sep 30, 2023 | $7.01M | -14.6% |
| Q2 FY2023 | Jun 30, 2023 | $4.60M | -58.3% |
| Q1 FY2023 | Mar 31, 2023 | $7.10M | -44.1% |
| Q4 FY2022 | Dec 31, 2022 | $5.88M | -60.9% |
| Q3 FY2022 | Sep 30, 2022 | $8.21M | – |
| Q2 FY2022 | Jun 30, 2022 | $11.03M | – |
| Q1 FY2022 | Mar 31, 2022 | $12.69M | – |
| Q4 FY2021 | Dec 31, 2021 | $15.04M | – |
See a number that looks wrong?